Manufacturer
118 recalls in our database name Martin Avenue Pharmacy, Inc. as the manufacturing or recalling firm.
Of the 118 recalls from Martin Avenue Pharmacy, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 37 (31%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Martin Avenue Pharmacy is voluntarily recalling Atropine sulfate 2 mg/mL injectable vials due to quality control issues that risk sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including triamcinolone injection solutions, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded morphine sulfate injectables due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including chlorhexidine gluconate ophthalmic solution, due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling benzalkonium chloride water for injection due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded Testosterone cypionate 200 mg/mL injections due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Pilocarpine 0.25% ophthalmic solution due to quality control issues that risk sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Atropine sulfate 0.5% ophthalmic solution due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling dexamethasone sodium phosphate injectable vials due to quality control issues that risk sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling trimethoprim/sulfadiazine excipient stock solution injections due to quality control issues that risk sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling compounded sterile preparations, including Quad mix 1, due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Lidocaine 1% injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling bacteriostatic water for injection due to quality control issues affecting sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix T108 injectable vials due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling veterinary injection suspensions due to quality control observations that present a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Histamine 0.55 mg/mL injectable vials because quality control observations during an FDA inspection raised concerns about sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix T25 injectable vials because quality control observations during an FDA inspection presented a risk to sterility assurance.
Martin Avenue Pharmacy is voluntarily recalling Hydroxocobalamin 10 mg/mL injectable vials due to quality control observations that present a risk to sterility assurance.